|
Volumn 2, Issue 4, 2005, Pages 182-183
|
What is the risk of second malignant neoplasms after childhood cancer?
|
Author keywords
Chemotherapy; Childhood cancer; Leukemia; Radiotherapy; Second malignant neoplasm
|
Indexed keywords
ALKYLATING AGENT;
ANTINEOPLASTIC AGENT;
GYRASE INHIBITOR;
ACUTE GRANULOCYTIC LEUKEMIA;
AGE DISTRIBUTION;
BONE CANCER;
BRAIN CANCER;
BREAST CANCER;
CANCER CHEMOTHERAPY;
CANCER INCIDENCE;
CANCER MORTALITY;
CANCER RADIOTHERAPY;
CANCER REGISTRY;
CANCER RISK;
CANCER SURVIVAL;
CENTRAL NERVOUS SYSTEM TUMOR;
CHILD;
CHILDHOOD CANCER;
COHORT ANALYSIS;
ENDOCRINE TUMOR;
FOLLOW UP;
HIGH RISK PATIENT;
HUMAN;
LEUKEMIA;
MULTIVARIATE ANALYSIS;
MYELODYSPLASTIC SYNDROME;
ONSET AGE;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
RISK ASSESSMENT;
RISK BENEFIT ANALYSIS;
SALVAGE THERAPY;
SECOND CANCER;
SHORT SURVEY;
SOFT TISSUE CANCER;
SOLID TUMOR;
STANDARDIZATION;
STATISTICAL SIGNIFICANCE;
UNITED KINGDOM;
CHILD;
EPIDEMIOLOGIC STUDIES;
HUMANS;
NEOPLASMS, SECOND PRIMARY;
RISK FACTORS;
|
EID: 20444472784
PISSN: 17434254
EISSN: None
Source Type: Journal
DOI: 10.1038/ncponc0129 Document Type: Short Survey |
Times cited : (4)
|
References (5)
|